Shortage Avoided

ROPIVACAINE HYDROCHLORIDE INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ROPIVACAINE HYDROCHLORIDE INJECTION, USP in Canada?

Not currently. The most recent shortage report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP 2MG is marked resolved (last updated July 15, 2022).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength2MG

Last updated2022-07-15

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02439379

Strength

2MG

Dosage Form

SOLUTION

Route

EPIDURAL INFILTRATION

Active Ingredient

ROPIVACAINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2022-07-15

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

ROPIVACAINE HYDROCHLORIDE INJECTION, USP has 2 shortage/discontinuation reports on file — this is one of them.

2026-06-16

Resolved

Demand increase for the drug.

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482